臨床泌尿器科76巻8号

2022年07月発行

特集 泌尿器腫瘍における放射線治療―変革期を迎えた令和のトレンド

〈前立腺癌〉

前立腺癌に対する高線量率組織内照射（HDR）の長期成績と最新状況

著者： 吉岡靖生¹

所属機関： ¹がん研究会有明病院放射線治療部

ページ範囲：P.534 - P.541

文献概要

▶ポイント

・高線量率組織内照射（HDR）は，小線源治療特有の線量集中性と1回大線量の超寡分割照射の2つの特性を併せもつ．

・HDRブーストでは外照射の前後にHDR 15Gy/1回が，HDR単独療法では27Gy/2回（2回刺入）が標準的な線量分割となりつつある．

参考文献

1） Kovács G, et al : Prostate Preservation by Combined External Beam and HDR Brachytherapy in Nodal Negative Prostate Cancer. Strahlenther Onkol 175 （Suppl 2） : 87-88, 1999

2） Yamada Y, et al : American Brachytherapy Society Consensus Guidelines for High-Dose-Rate Prostate Brachytherapy. Brachytherapy 11 : 20-32, 2012

3） Hoskin PJ, et al : GEC/ESTRO Recommendations on High Dose Rate Afterloading Brachytherapy for Localised Prostate Cancer : An Update. Radiother Oncol 107 : 325-332, 2013

）. Prostate Cancer. Version 4.2022　https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf （2022年6月1日閲覧）

5） Helou J, et al : High Dose-Rate Brachytherapy Boost for Intermediate Risk Prostate Cancer : Long-Term Outcomes of Two Different Treatment Schedules and Early Biochemical Predictors of Success. Radiother Oncol 115 : 84-89, 2015

6） Henry A, et al : GEC-ESTRO ACROP Prostate Brachytherapy Guidelines. Radiother Oncol 167 : 244-251, 2022

7） Yoshioka Y, et al : High-Dose-Rate Interstitial Brachytherapy as a Monotherapy for Localized Prostate Cancer : Treatment Description and Preliminary Results of a Phase I/II Clinical Trial. Int J Radiat Oncol Biol Phys 48 : 675-681, 2000

8） Morton G, et al : Prostate High Dose-Rate Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer : Efficacy Results from A Randomized Phase II Clinical Trial of One Fraction of 19 Gy or Two Fractions of 13.5 Gy. Radiother Oncol 146 : 90-96, 2020

9） Hoskin PJ, et al : Randomised Trial of External-Beam Radiotherapy Alone or with High-Dose-Rate Brachytherapy for Prostate Cancer : Mature 12-Year Results. Radiother Oncol 154 : 214-219, 2021

10） Kent AR, et al : Improved Survival for Patients with Prostate Cancer Receiving High-Dose-Rate Brachytherapy Boost to EBRT Compared with EBRT Alone. Brachytherapy 18 : 313-321, 2019

11） Wedde TB, et al : Ten-Year Survival After High-Dose-Rate Brachytherapy Combined with External Beam Radiation Therapy in High-Risk Prostate Cancer : A Comparison with the Norwegian SPCG-7 Cohort. Radiother Oncol 132 : 211-217, 2019

12） Hsu IC, et al : Long-Term Results of NRG Oncology/RTOG 0321 : A Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiation Therapy for Adenocarcinoma of the Prostate. Int J Radiat Oncol Biol Phys 110 : 700-707, 2021

13） Åström L, et al : Two Decades of High Dose Rate Brachytherapy with External Beam Radiotherapy for Prostate Cancer. Radiother Oncol 127 : 81-87, 2018

14） Rodda S, et al : ASCENDE-RT : An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 98 : 286-295, 2017

15） Yoshioka Y, et al : High-Dose-Rate Brachytherapy as Monotherapy for Intermediate- and High-Risk Prostate Cancer : Clinical Results for a Median 8-Year Follow-Up. Int J Radiat Oncol Biol Phys 94 : 675-682, 2016

16） Hauswald H, et al : High-Dose-Rate Monotherapy for Localized Prostate Cancer : 10-Year Results. Int J Radiat Oncol Biol Phys 94 : 667-674, 2016

17） Parzen JS, et al : Rates of Rectal Toxicity in Patients Treated with High Dose Rate Brachytherapy as Monotherapy Compared to Dose-Escalated External Beam Radiation Therapy for Localized Prostate Cancer. Radiother Oncol 147 : 123-129, 2020

18） Behmueller M, et al : High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up. Front Oncol 11 : 770959, 2021

19） Hoskin P, et al : Single-Dose High-Dose-Rate Brachytherapy Compared to Two and Three Fractions for Locally Advanced Prostate Cancer. Radiother Oncol 124 : 56-60, 2017

20） Gorovets D, et al : Early Outcomes of High-Dose-Rate Brachytherapy Combined with Ultra-Hypofractionated Radiation in Higher-Risk Prostate Cancer. Brachytherapy 20 : 1099-1106, 2021